Similar Search Results

Behind the scenes : sources of complementarity in R&D

Ceccagnoli, Marco; Higgins, Matthew J.; Palermo, Vincenzo - 2013

Persistent link: https://www.econbiz.de/10009722826

The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry

Banerjee, Tannista; Siebert, Ralph - 2014

Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...

Persistent link: https://www.econbiz.de/10010229875

Patents, data exclusivity, and the development of new drugs

Gäßler, Fabian; Wagner, Stefan - 2019

Pharmaceutical firms typically enjoy market exclusivity for new drugs from concurrent protection of the underlying invention (through patents) and the clinical trials data submitted for market approval (through data exclusivity). Patent invalidation during drug development renders data...

Persistent link: https://www.econbiz.de/10012064786

Dynamic effects of licensing and knowledge transfer across research stages : evidence from the pharmaceutical industry

Tian, Zhili; Siebert, Ralph - 2020

In the pharmaceutical industry, ﬁrms frequently engage in licensing agreements to overcome innovation challenges and …

Persistent link: https://www.econbiz.de/10012219514

Evaluation and Learning in R&D Investment

Frankel, Alex; Krieger, Joshua L.; Li, Danielle; … - National Bureau of Economic Research - 2023

We examine the role of spillover learning in shaping the value of exploratory versus incremental R&D. Using data from drug development, we show that novel drug candidates generate more knowledge spillovers than incremental ones. Despite being less likely to reach regulatory approval, they are...

Persistent link: https://www.econbiz.de/10014287391

Pharmaceutical research strategies

Phlippen, Sandra; Vermeersch, An - 2008

This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of successful research projects. We provide clear evidence that externally sourced projects and projects involving biotechnologies perform better than internal projects and chemical...

Persistent link: https://www.econbiz.de/10011374419

The development of firm size and innovativeness in the pharmaceutical industry between 1989 and 2010

Backfisch, Martin - 2018 - Version: 14 April 2018

Within the last decades, there have been many technological and regulatory changes in the pharmaceutical industry. Some of these developments facilitate the innovative activities of large firms, while others foster small firms. It is therefore surprising that the implications of these changes in...

Persistent link: https://www.econbiz.de/10011844257

Acquiring R&D projects: who, when, and what? : evidence from antidiabetic drug development

Malek, Jan; Newham, Melissa; Seldeslachts, Jo; … - 2024

This paper analyzes M&A patterns of R&D projects in the antidiabetics industry. For this purpose, we construct a database with all corporate individual antidiabetics R&D projects over the period 1997 - 2017, and add detailed information on firms' technology dimension using patent information,...

Persistent link: https://www.econbiz.de/10014468769

The impact of public basic research on industrial innovation : evidence from the pharmaceutical industry

Toole, Andrew A. - 2011 - This version: March 2011

While most economists believe that public scientific research fuels industry innovation and economic growth, systematic … size as a significant driver of drug innovation in the pharmaceutical industry, but they did not find any evidence … supporting science-driven innovation from publicly funded research. This paper uses new data on biomedical research investments …

Persistent link: https://www.econbiz.de/10009374417

Inter-firm R&D networks in the global pharmaceutical biotechnology industry during 1985 – 1998 : a conceptual and empirical analysis

Krogmann, Yin; Schwalbe, Ulrich - 2011

This paper analyses a large database on inter-firm R&D cooperation formed in the pharmaceutical biotechnology industry during the period 1985 - 1998. The results indicate that network size largely grows, whereas the density of the network declines during the periods. In the network analysis that...

Persistent link: https://www.econbiz.de/10009384892